A Phase II Study of Carboplatin Plus Irinotecan Versus Irinotecan in Children With Refractory Solid Tumors
Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
This clinical research study is being conducted to investigate the effectiveness of combining
carboplatin and irinotecan, versus irinotecan alone, in treating children who have refractory
solid tumors.